Next Generation Migraine Therapies
The Next Generation Migraine Therapies (NGMT) initiative is a comprehensive program designed to provide a multi-faceted approach to migraine education offered at no cost to healthcare providers. Brought to you by the American Headache Society, the program covers diagnosis and treatment of migraine, and updates on the latest science.
The NGMT program is now available virtually! The virtual program will center around pre-recorded lectures on new acute migraine treatments and prevention, behavioral approaches in migraine, and migraine diagnosis, epidemiology, and pathophysiology. Live Q&A sessions will be available on select dates (separate registration required.)
AHS gratefully acknowledges the educational support of the Next Generation Migraine Therapies Program from our industry supporters:
Allergan, an AbbVie company (NYSE: ABBV)
Eli Lilly and Company